摘要 |
A therapeutic composition that includes an active portion of the lysyl oxidase pro-peptide in a pharmaceutically acceptable carrier substance and methods of using such a therapeutic composition are disclosed. The active agent does not have lysyl oxidase enzymatic activity. Preferably, the active polypeptide is active in inhibiting cell growth in soft agar and active in inhibiting tumor formation. In addition, the active polypeptide preferably comprises an active portion of the amino acid sequence given in SEQ ID NO.: 1 or SEQ ID NO.: 2, or conservative substitions thereof. Alternatively, the active polypeptide comprises a polypeptide comprising an active portion of an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3-8, or conservative substitions thereof. |
申请人 |
TRUSTEES OF BOSTON UNIVERSITY;TRACKMAN, PHILIP, C.;PALAMAKUMBURA, AMITHA, H.;SONENSHEIN, GAIL, E.;JEAY, SEBASTIEN |
发明人 |
TRACKMAN, PHILIP, C.;PALAMAKUMBURA, AMITHA, H.;SONENSHEIN, GAIL, E.;JEAY, SEBASTIEN |